Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic – insights from the IRONMAN trial.
Saved in:
| Title: | Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic – insights from the IRONMAN trial. |
|---|---|
| Authors: | Lee, Matthew M.Y.1 (AUTHOR), Petrie, Mark C.1 (AUTHOR) mark.petrie@glasgow.ac.uk, Cleland, John G.F.1 (AUTHOR), Donnelly, Patrick2 (AUTHOR), Francis, Mark3 (AUTHOR), Hannah, Andrew4 (AUTHOR), Japp, Alan G.5 (AUTHOR), Labinjoh, Catherine6 (AUTHOR), Lang, Ninian N.1 (AUTHOR), Manisty, Charlotte7 (AUTHOR), Petrie, Colin J.1 (AUTHOR), Piper, Susan E.8 (AUTHOR), Williams, Simon G.9 (AUTHOR), Ford, Ian10 (AUTHOR), Kalra, Paul R.11,12,13 (AUTHOR) |
| Source: | European Journal of Heart Failure. Oct2024, Vol. 26 Issue 10, p2293-2295. 3p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
